Press Release: Tempus to Report Second Quarter 2024 Financial Results on August 6

Tempus to Report Second Quarter 2024 Financial Results on August 6 CHICAGO--(BUSINESS WIRE)--July 17, 2024-- Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine,

Dow JonesJul 17 09:30 ET

Tempus AI Shares Climb Following Launch of AI-Enabled Test

By Connor Hart Shares of Tempus AI rose after the company launched an artificial-intelligence-enabled test for research use. The stock was up 12%, to $40.92, in recent trading. The company went

WSJJul 16 13:06 ET

UnitedHealth Posts Better-Than-Expected Earnings, Joins AngioDynamics, Bank of America And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were mostly higher, with the Dow Jones index gaining around 550 points on Tuesday.Shares of UnitedHealth Group Incorporated (NYSE:UNH) rose sharply during Tuesday's session following a

BenzingaJul 16 11:09 ET

Tempus Expands Immuno-Oncology Portfolio With Launch of AI-enabled, Multimodal Immune Profile Algorithmic Tests

Available Today for Life Science Research Use Only Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, today announced that its multimodal immune profile score (IPS) algorithmic

BusinesswireJul 16 09:30 ET

Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures

In a recent development, Flagship Pioneering, the venture capital firm known for backing Moderna (NASDAQ:MRNA) has successfully secured a whopping $3.6 billion in funding.What Happened: Flagship

BenzingaJul 10 09:59 ET

Tempus Surpasses 500 Research Publications

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence and precision medicine, has reached a research milestone of over 500 research publications. In the last eight years, Tempus has invested in rigorous

BusinesswireJul 10 09:30 ET